© 2023 BioMarin. All rights reserved.

BioMarin to Participate in Two Upcoming Virtual Investor Conferences
- Evercore ISI 4th Annual HealthCONx Conference on December 1 at 1:25pm ET
- Piper Sandler 33rd Annual Healthcare Conference on December 2 at 1:30pm ET
Nov 29, 2021

SAN RAFAEL, Calif., Nov. 29, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in two upcoming virtual investor conferences.  An audio webcast of the presentations will be available live.  You can access the webcasts at: https://investors.biomarin.com/.  An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases.  The Company's portfolio consists of several commercialized products and multiple clinical and pre-clinical product candidates.  For additional information, please visit www.biomarin.com.  Information on such website is not incorporated by reference into this press release.




Traci McCarty              

Debra Charlesworth

BioMarin Pharmaceutical Inc.   

BioMarin Pharmaceutical Inc.

(415) 455-7558         

(415) 455-7451


SOURCE BioMarin Pharmaceutical Inc.